patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Is this good or not good?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Good point 7th. It would be rather difficult to go from .03 to 6.00 on the OTC no matter what the news.

I like the fact that being on the NAZ will permit intitutional investors in - hopeully Pluristem has them lined up.

I think it's safe to say that it all come down to news.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply